CLOSING AGREEMENTClosing Agreement • January 22nd, 2025 • Bioxytran, Inc • Pharmaceutical preparations
Contract Type FiledJanuary 22nd, 2025 Company IndustryThis Closing Agreement (the “Agreement”), dated as of January 15, 2025 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor” and, together with the Company, the “Parties” and, each, individually, a “Party”).
AMENDED AND RESTATED CLOSING AGREEMENTClosing Agreement • August 7th, 2023 • Asset Entities Inc. • Services-prepackaged software
Contract Type FiledAugust 7th, 2023 Company IndustryThis Amended and Restated Closing Agreement (the “Agreement”), dated as of August 1, 2023 (the “Issue Date”), is entered into between Asset Entities Inc., a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor” and, together with the Company, the “Parties” and, each, individually, a “Party”).
CLOSING AGREEMENTClosing Agreement • July 5th, 2023 • Asset Entities Inc. • Services-prepackaged software
Contract Type FiledJuly 5th, 2023 Company IndustryThis Closing Agreement (the “Agreement”), dated as of June 30, 2023 (the “Issue Date”), is entered into between Asset Entities Inc., Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor” and, together with the Company, the “Parties” and, each, individually, a “Party”).